Mucormycosis is a rare form of angioinvasive, rapidly progressive and lethal opportunistic fungal infection caused by Mucorales. 1,2 Due to the increase in predisposing factors in parallel with medical technological advances, the incidence of mucormycosis has increased significantly, especially in the wake of the second wave of the COVID-19 pandemic, which brought worldwide attention to this deadly yet neglected disease. 3,4 Although Rhizopus arrhizus is the most common causative agent of mucormycosis worldwide, Apophysomyces complex ranks second in the incidence of Mucorales infections in India. 5,6 Molecular phylogenetic studies in recent years have shown that the Apophysomyces complex includes five pathogenic species, namely Apophysomyces elegans, Apophysomyces ossiformis, Apophysomyces trapeziformis, Apophysomyces variabilis and Apophysomyces mexicanus. 7-11 A. variabilis was the most common causative agent of cutaneous mucormycosis. 12 Infections with A. variabilis have been reported